The Latest Cardiac and Vascular News
BEAUFORT, S.C.–(BUSINESS WIRE)–Research published by THE SAGE GROUP examines PAD disparities in African Americans and the contributing factors, as well as quantifies PAD prevalence in AA. “While it is well known that African Americans have a higher prevalence of PAD, […]
JERUSALEM, May 2, 2022 /PRNewswire/ — VOTIS Subdermal Imaging Technologies Ltd. announced today that it has enrolled the first patient in the feasibility study of its PedCheckTM device at Hadassah Medical Center in Jerusalem, Israel. The pilot study, entitled “The Use of Hemodynamic Occlusive Vascular Response (HOVR™) technology […]
First clinical trial to evaluate the safety & efficacy of RT234 on exercise parameters assessed by Cardiopulmonary Exercise Testing (CPET) PALO ALTO, Calif., April 5, 2022 /PRNewswire/ — Respira Therapeutics, Inc. a clinical-stage company developing inhaled therapeutics for cardiopulmonary diseases that improve patient […]
Through Save Legs. Change Lives.™, Janssen seeks to elevate PAD research, collaboration, education and screening for communities placed at increased risk of cardiovascular disease TITUSVILLE, N.J., March 31, 2022 /PRNewswire/ — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the launch […]
CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the achievement of a milestone with the enrollment of 100 subjects in its pivotal clinical […]
Phase 2a clinical trial evaluating REG-101 for PAD expected to initiate second half of 2022 ROCKVILLE, Md.–(BUSINESS WIRE)–Regio Biosciences (Regio), a Hibiscus BioVentures company, announced today it has entered into an exclusive license agreement with AstraZeneca to further develop REG-101, a novel therapeutic acting […]
Bloomington, Ind. — Cook Medical has received Breakthrough Device designation from the US Food and Drug Administration (FDA) on a new drug-eluting stent for below the knee (BTK). This new stent is designed to treat patients suffering from chronic limb-threatening ischemia […]
The TORUS 2 study is a prospective, single-arm trial of 188 patients to evaluate safety and effectiveness of the TORUS Stent Graft System in the treatment of PAD in the SFA and proximal popliteal arteries IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a […]
– One in four physicians surveyed feel the “lack of technology or equipment to make an accurate diagnosis of coronary artery disease and peripheral artery disease” is a key obstacle to an accurate diagnosis – Over a third of surveyed […]
Disrupt PAD III Observational Arm Confirms IVL Safely and Effectively Modifies Superficial and Deep Calcium in Complex Calcified Lesions SANTA CLARA, Calif., Oct. 06, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization […]
